Infertility is a global health problem with an estimated incidence of 15%. Exposure to chemicals is a potential causal factor, and there is a lack of studies examining the effects on female germ cells. Here, we have studied the impact of different aryl hydrocarbon receptor (AHR) modulators on human ovarian follicles using a human ovarian tissue culture model. Expression of AHR was analyzed in tissue samples, and effects of the selected ligands resveratrol (RSVL), 6-formylindolo(3,2-b)carbazole (FICZ), and alpha-naphthoflavone (aNF) on AHR transactivation studied in a granulosa cell tumor line. Cortical human ovarian tissue containing preantral follicles was exposed to the ligands or vehicle (dimethylsulfoxide, DMSO) for seven days in vitro. Follicle growth was assessed by counting and measuring follicles from serial tissue sections, cell death quantified using in situ Terminal deoxynucleotidyl transferase dUTP Nick-End Labeling (TUNEL) assay, and steroid hormone production measured using a newly developed ultra-performance liquid chromatography method. AHR was expressed in all donated ovarian tissue samples. FICZ induced AHR transactivation in the granulosa cell line while aNF antagonised it. Compared to DMSO control, FICZ had no effect on follicles in culture, RSVL increased the proportion of growing follicles, and aNF increased cell death, disrupted growth of secondary follicles, increased testosterone, and reduced estradiol levels. We conclude that RSVL supports and aNF disrupts growth of human ovarian follicles in culture. We further conclude that the human ovarian tissue culture model is suitable for studying effects of chemicals on follicular biology.
Introduction
Human ovarian follicular reserve is finite. All follicles are generated during fetal life, and thereafter degenerate through atresia until menopause marks the end of the ability to conceive a child (Hansen et al., 2008) . Typically, only a single oocyte is ovulated every month from a cohort of maturing follicles, thus making eggs a major limiting factor in human reproduction. Full maturation from the primordial to the ovulatory stage takes approximately six months in the human and is tightly controlled by the endocrine hypothalamus-pituitary-gonadal axis plus local ovarian growth factors. Thus, this complex process could be adversely affected by exposure to endocrine disrupting chemicals (EDCs).
EDCs are "exogenous substances or mixtures that alter the function (s) of the endocrine system and consequently cause adverse health effects in an intact organism, or its progeny, or (sub)populations" (Bergman et al., 2013; Gore et al., 2015) . There are approximately 100,000 chemicals registered in the US and EU (TSCA and REACH databases) , and biomonitoring studies show that mixtures of chemicals can be found in serum of virtually every human being (Crinnion, 2010) . Pregnant women are not an exception, and detection of industrial chemicals in amniotic fluid and cord blood demonstrate that exposure of an individual begins during fetal development (Woodruff et al., 2011; Morello-Frosch et al., 2016) . Exposure to EDCs is a potential threat to female reproductive health (Crain et al., 2008; Bergman et al., 
Materials and methods

Study participants and ethical approval
Women undergoing elective caesarian sections at the Karolinska University Hospital Huddinge, Sweden, were recruited to the study. All participants received oral and written information on the project, and gave their consent. A thin piece of the ovarian surface (≈ 5 × 2 mm) was biopsied from seven women. Tissue was collected in warm phosphate buffered saline in the operating theatre and transported to the research laboratory for processing and culture within five minutes. All women were generally healthy and had no known existing morbidities. Participant #2 (38 years) had polycystic ovaries, and Participant #7 (39 years) conceived with the assistance of in vitro fertilization. The tissue of Patient #7 was found to contain no follicles and neither did it produce steroids in culture. This study was approved by the Regional Ethics Board at the Karolinska Institutet (license number 2010/549-31/ 2, 2010-05-19).
Tissue culture
Freshly collected tissue was processed using sterile scalpels and a spatula under a Nikon SMZ1500 stereomicroscope (Melville, NY, USA) in a laminar flow hood. Cortical tissue was cut into small cubes of approximately 1 mm 3 in size. The experimental setup is depicted in Fig. 1 .
Tissue fragments left over from trimming the samples for culture were stored in −80°C for AHR and AHRR expression analyses, and the trimmed tissue cubes were randomly distributed to five different study groups: untreated control tissue, or tissue cultured with 0.1% DMSO, 10 − 5 M RSVL, 10 − 8 M FICZ, or 10 − 5 M aNF. FICZ (CAS 172922-91-7) was purchased from Enzo Life Sciences (New York, NY, USA), and aNF (CAS 604-59-1) and RSVL (CAS 501-36-0) from Sigma-Aldrich (St. Louis, MO, USA). Sample sizes for treatments are described in Supplementary Table 1 . All compounds were dissolved in DMSO as 1000-fold concentrated working stock solutions, and added to the culture media at 0.1% (vol/vol) to obtain the final concentrations. Vehicle control consisted of 0.1% (vol/vol) DMSO only. The chemical structure of the treatment compounds and their reported binding affinity for AHR are shown in Supplementary Fig. 1 . Culture media consisted of high glucose DMEM (no phenol red, no glutamine) supplemented with 10% human serum albumin solution, 1% Glutamax I, 1% insulin-transferrin-selenium, 1% antibiotic-antimycotic, and 0.5 IU/ml follicle stimulating hormone (FSH) (Gonal-F). All reagents were purchased from Life Technologies (Grand Island, NY, USA), with the exception of human serum albumin solution (Vitrolife, Göteborg, Sweden) and FSH (Serono Nordic, Solna, Sweden).
Culture conditions mimicked the air-liquid interphase system reported for mouse testes (Steinberger et al., 1964; Sato et al., 2011) . A 0.5% gel was prepared by dissolving agarose in ddH 2 O. Pillars of agarose were cut with a sterile 1 ml pipette tip, placed in 24 well plates, and equilibrated over night with 0.8 ml culture media in a Galaxy R incubator (Eppendorf, Hamburg, Germany) in +37°C and 5% CO 2 . The following day media were replaced with treatment media containing the study compounds, and tissue cubes were placed on the pillars. Tissue was kept in culture for seven days, and 50% of the media volumes were changed to fresh media every other day.
Tissue analysis
Tissue was fixed in Bouin's solution and embedded into paraffin. Serial sections were prepared to a thickness of 4 μm. Every 10th and 11th section was hematoxylin-eosin (HE)-stained and the sections were scanned with Mirax Slide Scanner (Zeiss, Göttingen, Germany) at 20× objective, and follicles were counted and scored using Panoramic Viewer software (3DHistech, Budapest, Hungary). To avoid duplicate counting of follicles, only those follicles with a visible oocyte were taken into consideration, and they were followed through the adjacent sections. Follicles were scored into categories, consisting of degenerating, primordial (dormant), primary and secondary. Follicles were considered degenerating if the oocyte was eosinophilic, of irregular shape or had crumped chromatin, or if the follicle had > 5% pyknotic granulosa cells. Dormant follicles were defined as those surrounded by one layer of flattened granulosa cells; primary follicles were determined by one partial or complete layer of cuboidal granulosa cells; secondary follicles had two or more layers of cuboidal granulosa cells. The size of secondary follicles and oocytes was measured using the Panoramic Viewer software. Size of secondary follicles of healthy morphology with a visible oocyte nucleus was measured by taking two perpendicular measures for both the oocyte and the follicle. The mean of each measure was used for statistical analysis. To calculate cell densities in secondary follicles, the number of granulosa cell nuclei visible in a cross-section of a follicle was manually calculated in those healthy follicles where the oocyte nucleus was visible. The granulosa cell density for each follicle was calculated as (number of nuclei)/((area of the follicle) − (area of the oocyte)).
Terminal deoxynucleotidyl transferase dUTP Nick-End Labeling (TUNEL) assay
Cell death in cultured tissue was measured with the In Situ Cell Death Detection Kit, Fluorescein (Roche, Penzberg, Germany) following manufacturer's instructions. Briefly, dewaxed and rehydrated tissue sections were treated with proteinase K, incubated with the TUNEL reaction mixture for 1 h at 37°C, and then mounted with VECTASHIELD Antifade Mounting Medium with DAPI (Vector laboratories, Peterborought, UK). Positive controls were treated with DNase I for 20 min at room temperature prior to TUNEL reaction. Negative controls were incubated with buffer only instead of TUNEL reaction mixture. Images were taken with Olympus IX-81 microscope fitted with Olympus XM10 camera. Fluorescein (TUNEL) and DAPI were excited with 470-495 nm and 360-370 nm filters, and emission was collected with 510-550 nm and 420-460 nm filters, respectively. The same imaging parameters were used for the whole set of samples. Fluorescence was quantified with ImageJ image processing and analysis software. Integral Optical Density (IOD) was measured for each image in the green channel, and the DAPI positive nuclei were counted on the blue channel. The IOD value was then normalized to the cell count. Signal was quantified separately for stroma and follicles. The numbers of images analyzed are described in detail in Supplementary Table 2 .
To analyze cell density in stroma and follicles, the numbers of DAPI positive nuclei were divided by the associated area. Calculations were done separately for stroma and follicles. All follicle types were included.
Cell culture experiments
Effects of the ligands on AHR transactivation were measured in the human granulosa cell tumor line KGN that was purchased from the RIKEN cell bank (Ibaraki, Japan). Cells were cultured in DMEM:HamF12 (Life Technologies, Grand Island, NY, USA) and supplemented with 10% inactivated fetal bovine serum (Gibco, US) and 100 U/ml penicillin-streptomycin (Life Technologies, Grand Island, NY, USA). For the proliferation assay, cells were plated in 96 well plates at a density of 5000 cells/well, and treated with the test substances (10 Gene expression in the freshly donated tissue samples (donors #1-#7, n = 7) and cell lines was analyzed using qPCR. RNA was extracted using the RNeasy Mini Kit (Qiagen, Hilden, Germany) with oncolumn DNase treatment following the manufacturer's instructions. A total amount of 1 μg RNA was reverse transcribed to cDNA using the InVitrogen SuperScript III First-Strand Synthesis Supermix kit. Quantitative PCR analysis was carried out using Fast SYBR Green Master Mix (Life Technologies, Grand Island, NY, USA). Human Ovary Poly A + RNA (Clontech, Mountain View, CA, USA) and FirstChoice Human Placenta Total RNA (Life Technologies, Grand Island, NY, USA) were used as reference material. Gene expression analyses were performed using primers as described in Table 1 . The analysis was carried out using the standard fast qPCR program in the Applied Biosystems 7500 Fast Real-Time PCR system (Life Technologies, Grand Island, NY, USA). Each sample was run in technical duplicate and the whole experiment repeated three times. The specificity of primers was determined by melt curve analysis and agarose gel electrophoresis.
Hormone measurement in conditioned culture media
Culture media from days 2 and 6 of culture were analyzed for steroid hormone concentrations using a protocol based on liquid/liquid extraction in combination with UPLC-MS/MS. Although the tissue cubes were cultured individually in separate wells, the media from each time point and treatment per patient were pooled for analysis. This left us with four separate samples (DMSO, RSVL, FICZ, aNF) per time point (2 days, 6 days) per patient (n = 6). Initially, steroids were extracted by mixing 0.5 ml of culture media with 50 μl of internal standards dissolved in methanol. The internal standards were isotopically labeled analogues ( 13 C or 2 H) for each steroid (n = 10) included in the platform at a concentration range of 0.05-10 ng/ml. Subsequently, 20 μl of 25% NH 4 OH was added, followed by 1000 μl of metyl-tert-buthyl ether and vigorously vortexing each sample for 4 min. To aid phase separation, the samples were centrifuged for 2 min at 5 G and the supernatants were then transferred to glass inserts and vacuum centrifuged to dryness. The samples were lastly reconstituted in 100 μl of methanol:H 2 O Table 1 Oligonucleotide primer sequences for qPCR. AHR: aryl hydrocarbon receptor; AHRR: aryl hydrocarbon receptor repressor; CYP1A1: cytochrome 450 family 1 subfamily A member 1; CYP1B1: cytochrome 450 family 1 subfamily B member 1; RPLP0: ribosomal protein lateral stalk subunit P0; HPRT1: hypoxanthine phosphoribosyltransferase 1.
Genes
Accession number Primers
in a ratio of 1:1 before 40 μl of each samples was injected on the UPLC-MS/MS setup. steroid. Desolvation gas flow and temperature was set to 1000 l/h and 550°C respectively. The samples were injected once, and the monitored steroids in elution order were; aldosterone (Ald), cortisol (C), corticosterone (Cor), estradiol (E2), androstenedione (A), testosterone (T), 17α-OH-progesterone (17OH-P), dehydroepiandrosterone (DHEA), dihydrotestosterone (DHT), and progesterone (P). Quantification was achieved by external calibrators (n = 9) made in human serum spiked with known amounts (~1 pM to 50 nM) of each steroid. Internal quality controls (QCs) made in serum were also included in the analysis batch, as well as external QCs (AbsoluteIDQ® Steroid Quality Controls, Biocrates, Innsbruck, Austria) at low/medium/high levels. A more detailed description of the UPLC-MS/MS settings for each of the steroids can be found in Supplementary Table 3 .
Statistical analyses
Data regarding frequency of follicles in different categories (degenerating vs. healthy; dormant vs growing) were analyzed using contingency tables. All treatments were first assessed in one table, and in case of significant findings (p < 0.05) pair-wise comparisons were made between treated groups. Bonferroni was used to correct multiple comparisons. Dependencies between variables (oocyte and follicle sizes, follicle density and E2/T ratio) were tested by calculating Pearson correlation coefficients (R) with associated t-and p-values. Continuous data with one categorical predictor (TUNEL, cell densities, follicle sizes, qPCR results) were analyzed using one-way ANOVA and data with two categorical predictors (qPCR results, proliferation assay, steroid data) using two-way ANOVA followed by Tukey HSD post hoc test in case of significant findings (p < 0.05). Normality was tested with ShapiroWilk test and inspection of Q-Q plots. The steroid data were Log2 transformed to bring the distribution to normality. Data in bar charts are presented as mean + SEM and in box plots as median, interquartile range (box) and non-outlier range (whiskers). Outliers are defined as those values differing > 1.5 inter-quartile ranges from the box, and shown as dots. Differences were considered significant when p < 0.05. The numbers of observations are given in figures and in Supplementary  Tables 1 and 2 . The statistical analyses were carried out with StatSoft, Inc. (2014) STATISTICA version 12 (Tulsa, OK, USA) and R version 3.4.1 (2017) (Vienna, Austria).
Results
AHR transactivation in KGN cells
The effect of the study ligands on AHR transactivation was measured in the human granulosa cell tumor line KGN. Cells were cultured in the presence of FICZ, aNF, or RSVL for 5 and 48 h, and mRNA expression of the AHR target genes CYP1A1 and CYP1B1 measured by qPCR ( Fig. 2A) . The strong agonist FICZ significantly induced at 10 − 9 and 10 − 8 M concentrations the expression of CYP1A1 at both time points, and CYP1B1 at the 48 h time point (Fig. 2A) . The antagonists aNF and RSVL had no effects on basal CYP1A1 or CYP1B1 expression, as expected ( Fig. 2A) . ANF significantly reduced FICZ-induced CYP1B1 expression. RSVL had no significant effects. (Fig. 2B) . The tested concentrations were not toxic to the cells as they did not affect proliferation ( Supplementary Fig. 2 ).
Tissue samples and follicle growth in culture
All biopsied tissue samples were thin cortical slices and the age of donors ranged from 28 to 39 (mean 34.2) (Supplementary Table 1 ). The samples were freshly processed and placed in culture within 30 min from biopsy. Expression of AHR and AHRR was verified in every biopsy sample by qPCR and compared to commercial human ovary and placenta RNA, as well as to different cell lines. AHR cDNA was detected in all samples and the mean expression level was higher than in the commercial reference ovary sample (Fig. 3) . The expression levels of the repressor AHRR were very low in all samples except for the KGN cell line (Fig. 3) .
Entire tissue material was processed to serial sections, and follicles counted and scored from HE-stained sections. Total number of follicles in the entire tissue material from the seven donors was 4214, and they were evenly distributed between the treatment groups (Supplementary Table 1 ). Proportions of healthy and degenerating follicles varied significantly (X 2 = 646.7, df = 4, p < 0.0001). The proportion of degenerated follicles was higher in all culture conditions compared to untreated control (untreated vs. DMSO: X 2 = 420.7, df = 1, p < 0.001; untreated vs. RSVL: X 2 = 313.3, df = 1, p < 0.0001; untreated vs. FICZ: X 2 = 458.0, df = 1, p < 0.0001; untreated vs. aNF: X 2 = 467.0, df = 1, p < 0.0001) but no differences were found between cultured samples (Fig. 4A) . Dormant (primordial) and growing (primary and secondary) follicles were differently distributed among the groups (X 2 = 99.2, df = 4, p < 0.0001) (Fig. 4B ). The proportion of growing follicles increased in all culture conditions compared to untreated control (untreated vs. DMSO: X 2 = 8.8, df = 1, p < 0.05; untreated vs. RSVL: X 2 = 90.5, df = 1, p < 0.0001; untreated vs. FICZ: X 2 = 25.7, df = 1, p < 0.0001; untreated vs. aNF X 2 = 36.6, df = 1, p < 0.0001). Tissue cultured in the presence of RSVL contained significantly higher proportion of growing follicles compared to DMSO control (X 2 = 30.2, df = 1, p < 0.0001) (Fig. 4B) . Examples of follicle morphology after culture are presented in Supplementary Fig. 3 . Since all follicles with more than one layer of granulosa cells are classified as secondary regardless of their size, growth was further studied by measuring their diameter. In untreated control material, only two secondary follicles with visible oocyte nuclei were found and they measured approximately 90 μm in diameter. The majority of secondary follicles in the cultured tissues were small, < 90 μm, most likely reflecting the recent recruitment to the growing pool ( Supplementary  Fig. 4 ). Every cultured group had a few larger follicles, > 90 μm in size, which could stem from secondary follicles already present in the biopsied tissues at the start of the culture. There were no statistically significant differences in regard to follicle size between the groups ( Supplementary Fig. 4) .
During preantral growth, the follicle diameter increases due to proliferation of the granulosa cells as well as growth of the oocyte. We tested whether there is a correlation between oocyte and follicle diameters by calculating Pearson correlation coefficients. A significant positive correlation was found between oocyte and follicle diameters in DMSO, RSVL and FICZ treatment groups but not in the aNF group (Fig. 5) , suggesting that aNF disrupts the growth of secondary follicles. We examined further the growth of the follicles by quantifying the number of cells per somatic cell area in a follicle cross-section using both HE-stained sections and DAPI staining in the TUNEL samples. The granulosa cell density in follicles did not differ between the treatment groups ( Supplementary Fig. 5 ).
Cell death
Cell death was measured using an in situ TUNEL kit that labels nicked DNA with a fluorescent dye. In general, the staining pattern revealed a contrast between cortical stroma and follicles. At the end of the culture, the stroma was clearly more TUNEL positive than the follicles (Fig. 6A) . TUNEL positive cells could be observed immediately adjacent to the TUNEL negative granulosa cells in the follicle in cultured but not uncultured tissue (Supplementary Fig. 6 ). The TUNEL positive area of the tissue in next available HE-stained section revealed the presence of pyknotic nuclei, validating the TUNEL positive cells as apoptotic ( Supplementary Fig. 6 ). Quantification of the TUNEL signal showed that aNF treatment led to significantly increased cell death both in stroma and follicles (Fig. 6B ). The other treatments had no significant effects on cell death.
Steroids in culture media
Follicle viability and function was further studied during culture by measuring steroid hormones in conditioned culture media. We developed a UPLC-MS/MS based method for analysis of 10 different steroid hormones in small volumes of sample with expected low concentration of analytes. The steroids that could be quantified in the samples were P, 17OH-P, DHEA, A, T, and E2, all present at nM levels. The responses were well above the lower calibration range that was in the low pM range (Supplementary Table 3 ). In order to ensure that the obtained concentrations from the steroid analysis were correct, we also analyzed external quality controls in parallel with the culture medium samples. These external QCs are designed for quality assurance purposes and are based on pooled human serum. All of the 10 steroid hormones in the method were represented in these external QCs at low, medium and high levels with a well-established reference value of each steroid. The relative difference between the reference value and our measured value of each steroid was used as an estimate of the method's accuracy and can be found in Supplementary Table 4 . We use acceptance criteria of ± 20% in the low range and ± 15% in the medium to upper range is used. By these criteria, only 4 out of 30 steroid measurements exceeded this criteria (Ald 24%, DHEA -27%, C -56% & 17α-OHP −20%) showing an overall satisfactory method reliability in the steroid analysis. Additional characteristics of the UPLC-MS/MS method from the validation of the method are also listed in Supplementary Table 4 .
The basal media did not contain complex serum, which was reflected by the extremely low levels of steroids (0 pM P, 2.6 pM 17OH-P, 0 pM DHEA, 2.2 pM A, 1.4 pM T, and 0 pM E2). The levels of all six detected hormones rose during culture in all samples, except in those derived from Patient #7. Her tissue was histologically confirmed to contain no follicles (Supplementary Table 1 ) and the sample was omitted from further analyses regarding steroids. The most abundant steroid was P, followed by DHEA and A, all detected at nM concentrations (Fig. 7A) . Statistical analysis of the data found significant time effects for the concentration of P (Fig. 7A) . The steroid profile in the DMSO, RSVL and FICZ treatment groups was in general similar to each other. Tissue treated with aNF secreted higher mean level of P, A and T, and lower E2 at the end of culture compared to the other groups (Fig. 7A) .
We analyzed the data further by calculating the ratios between steroids (product divided by precursor) in all individual samples. ANOVA analysis indicated that both time and treatment had significant effects on the E2/T ratio (Fig. 7B) . The ratio was significantly lower in the aNF group at the end of the culture compared to DMSO (p < 0.05), FICZ (p < 0.05) and RSVL (p = 0.06). In addition to the E2/T ratio, significant effects were found in 17OHP/P ratio, which was lower on day 6 compared to day 2 ( Supplementary Fig. 7 ). The variation in steroid levels between patient samples was high, and probably reflected the variation in follicle densities. There was a positive correlation between the Log2(E2/T) ratio and follicle density in all groups except for that treated with aNF (Fig. 7C ).
Discussion
In this study, we have tested whether effects of AHR ligands on human ovarian follicle activation, growth, death and function can be studied in tissue culture conditions. The ligand activities were verified in an AHR transactivation assay in human granulosa cell line KGN, and FICZ was found to be an agonist and aNF an antagonist as expected. RSVL slightly reduced the average CYP1B1 expression, but the effect did not reach statistical significance. The ovarian tissue samples used in the experiments were verified to express AHR. We focused on three main aspects of follicle biology: recruitment to the growing pool, survival/death, and steroidogenesis. These endpoints were evaluated through morphological assessment of HE-stained serial tissue sections, measurement of follicle and oocyte size, detection of apoptosis through TUNEL assay, and analysis of steroid hormones in conditioned culture media.
All culture groups showed a typical pattern of follicle growth in vitro with an increase in both the numbers of degenerating and growing follicles (Hovatta et al., 1997; Telfer et al., 2008) . The actual slicing of the tissue promotes follicle activation through disruption of the Hippo signaling pathway, and when the sliced tissue is transplanted to patients or xenografted to mice, follicle growth will continue to the antral stages (Kawamura et al., 2013) . However, full follicular maturation from primordial to antral stages is a rare event in in vitro follicle culture, and the specific factors required to support robust follicle growth from dormancy to maturity are still unknown. Even in endogenous settings only a small fraction of follicles reach maturity while the majority degenerate through atresia. Whether the generally poor follicular survival in in vitro cultures depends on intrinsic properties of the follicles, or suboptimal culture conditions, still remains to be shown. Since a large proportion of follicles degenerates in ovarian tissue culture systems, a large number of follicles is needed for statistical analysis. In our study, over 4000 follicles were evaluated, and one third of these remained alive at the end of culture based on morphology.
Tissue cultured with RSVL had more growing follicles than DMSO control at the end of the culture suggesting that RSVL promotes activation of human ovarian follicles in culture. Similar findings have been reported in experimental animals, where female mice treated with RSVL for 12-months had more primordial and growing ovarian follicles compared to control (Liu et al., 2013) . In rats, RSVL promoted the number of healthy follicles as well as decreased atresia (Chen et al., 2010) . The mechanisms through which RSVL stimulate follicle growth are not clear, but may involve effects on AHR activity, estrogen signaling, sirtuins, telomerase length, cellular senescence (Baur and Sinclair, 2006; Liu et al., 2013) , or mTOR signaling. In particular, mTOR is a central player in follicle activation (Zhang and Liu, 2015) . Permanent activation of Mtor through deletion of its repressors leads to global activation of follicles, and Mtor knockdown prevents follicle activation in mice (Zhang and Liu, 2015) . RSVL is an inhibitor of mTOR, similar to rapamycin. Short term rapamycin treatment in mice leads to increased number of resting follicles and decreased number of growing follicles resulting in increased ovarian life span, suggesting that Mtor inhibition prevents recruitment of follicles to growing pool (Dou et al., 2017) . In human ovarian follicle culture rapamycin treatment leads to loss of follicles without increase in apoptotic markers (McLaughlin et al., 2011) . Possible effects on follicle activation and growth were not reported. Similar to rapamycin, RSVL prolongs reproductive life span by maintaining higher ovarian reserve than control mice (Liu et al., 2013) . Perhaps both rapamycin and RSVL exposures slow down follicle activation and initial growth through mTOR. In our culture experiments, the tissue was sliced before culture and the follicles were therefore most likely activated to grow through Hippo signaling prior to exposures (Kawamura et al., 2013) . Thus, RSVL could affect follicle growth by inhibiting the already active mTOR. The group treated with RSVL had more primary follicles than the other groups, which could indeed suggest slower growth. In the human, preantral growth of follicles is due to somatic cell proliferation and oocyte growth. We found a positive correlation between follicle and oocyte diameters in our samples in all cultured groups except for aNF, suggesting that aNF disrupts the normal growth pattern of secondary follicles. aNF has been shown to inhibit human granulosa cell growth in vitro (Horling et al., 2011) . However, our analyses of KGN cell proliferation and cell densities in cultured follicles and ovarian stroma did not reveal any significant effects of aNF at studied concentrations. Instead, the disruption of follicle growth could be due to an effect on steroidogenesis, as discussed below.
We set up a novel mass spectrometric method for quantification of steroid hormones in the conditioned culture media. The method enables simultaneous detection and quantification of 10 different steroids belonging to progestogens, mineralocorticoids, glucocorticoids, androgens, and estrogens. Our culture media contained human serum albumin instead of fetal bovine serum, which gave a very clean background for steroid measurements; the basal culture media were virtually steroid-free. In line with expected steroidogenic profile of ovarian follicles, we did not detect aldosterone, cortisol, corticosterone or dihydrotestosterone in the samples (Andersen and Ezcurra, 2014) . Instead, the follicle derived steroids P, 17OH-P, A, DHEA, A, T and E2 were easily detected and quantified at both measured time points, day 2 and day 6. Since we changed half of the medium every other day, the measured concentrations are likely to be lower than the true steroid production during the study. The presence of steroids representing full ovarian steroidogenesis from P to E2 indicates that the cultures contained theca cells in addition to the granulosa cells, as theca cells are the location of DHEA, A and T synthesis. These results verify that a Table 2 . Neg ctrl consisted of tissue treated with buffer only instead of TUNEL reagent, and Pos ctrl consisted of tissue treated with DNase I prior to staining. Data were analyzed with ANOVA followed by Tukey HSD and the differences to Neg ctrl are marked as **p < 0.01, ***p < 0.001, to untreated tissue as #p < 0.05, and to DMSO as §p < 0.05.
proportion of follicles remain alive and functional throughout the seven-day culture period.
Ratios between steroids along the steroidogenic pathway were calculated to estimate the conversion rates, which could reflect the activity of steroidogenic enzymes. The ratio between 17OHP and P (CYP17α hydroxylase) was significantly reduced during the culture, which could be either due to reduced activity or expression of the enzyme, or perhaps dominance of the Δ5-pathway (pregnenolone to 17OH-pregnenolone) over the Δ4-pathway (P to 17OHP). The E2/T ratio was significantly affected by time and treatment. The ratio rose during culture, which may suggest activation of CYP19 aromatase in the granulosa cells. The culture media contained FSH, which is a known inducer of CYP19. On day 6 of culture, aNF group had a significantly lower E2/T ratio compared to other groups in the same time point. aNF Fig. 7 . Steroid hormone production during the follicle culture. A) The concentrations of progesterone, 17α-hydroxyprotesterone (17OH-prog), dehydroepiandrosterone (DHEA), androstenedione, testosterone and 17β-estradiol were measured in basal culture media (baseline) and on days 2 and 6 of culture by UPLC-MS/MS. The data were presented as mean + SEM (n = 6 representing individual donors). Statistical analyses were performed using ANOVA on Log2-transformed values. B) E2/T ratio on days 2 and 6 of culture in the different culture groups. Log2-transformed ratios are shown as box plots consisting of median, interquartile range and non-outlier range. Data were analyzed with ANOVA and Tukey HSD test. Differences are marked with *p < 0.05. C) Correlation between follicle density and Log2-transformed E2/T ratio on day 6 of culture. Pearsson correlation coefficients (R) with associated t-and pstatistics are shown.
is a known potent competitive inhibitor of CYP19 aromatase (Kao et al., 1998) , and our steroid results show that it does lead to increase in T and decrease in E2 in follicle cultures, suggestive of aromatase disruption.
Although the steroid results verify follicle viability, the cell death assay suggests that stromal cells were not thriving in culture. The general staining pattern in all cultured groups showed pronounced cell death in stroma that was largely absent in follicles. Cultures exposed to aNF had increased TUNEL signal both in follicles and stroma. This is somewhat surprising, since activation of AHR, not inhibition, is reported to trigger death in ovarian follicles. For example, when AHR/ Ahr is activated by 9,10-dimethylbenz[a]anthracene it stimulates apoptosis in human and rodent ovarian follicles, and co-treatment with inhibitors such as aNF and RSVL prevents adverse effects (Mattison and Thorgeirsson, 1979; Matikainen et al., 2001) . However, the lack of Ahr activity might be detrimental to follicles too, since Ahr knockout mouse ovaries age faster than wildtype (Benedict et al., 2003) . It could be hypothesized that aNF disrupted the balance of AHR activity in the samples, leading to adverse effects on tissue survival. Another explanation to tissue apoptosis in aNF cultures could be related to the reduction in estradiol production. Estradiol is a known mitogen and essential for antral follicle growth and ovulation, although its role in preantral follicles is less clear (Dewailly et al., 2016) .
FICZ did not affect any of the measured parameters. FICZ is the strongest known ligand for AHR (Rannug et al., 1987; Rannug et al., 1995; Oberg et al., 2005) , and the concentration we used should clearly be enough to transactivate AHR considering its very high affinity for the receptor (dissociation constant k d = 7 * 10 −11 M) (Rannug et al., 1987; Rannug et al., 1995) and the fact that CYP1A1 and CYP1B1 expression was stimulated in KGN cells. The lack of effects on follicles could depend on ligand-specific selective modulation of AHR (Denison et al., 2011) . For example, 2,3,7,8-tetrachlorodibenzo-p-dioxin is a much less potent stimulator of follicular apoptosis than 9,10-dimethylbenz[a]anthracene although it is also a strong AHR agonist (Mattison and Nightingale, 1980; Matikainen et al., 2001 ). In summary, our results suggest that the AHR antagonist aNF has deleterious effects on human follicles as it increased apoptosis, disrupted secondary follicle growth, and disrupted conversion of T to E2. These effects could involve CYP19 inhibition in addition to AHR inhibition. The other tested putative AHR inhibitor, RSVL, was not able to significantly reduce AHR transactivation in KGN cells, and might not be an effective AHR antagonist in ovarian tissue. The effects of RSVL on follicles were different from aNF too. RSVL increased the fraction of small growing follicles. The role of mTOR in these effects should be addressed in future studies.
We conclude that our culture model based on donated human ovarian tissue is well suited for assessing effects of chemicals on follicle growth, viability and steroidogenesis. Further development of the model could include optimization of the culture conditions to ensure better survival of stroma, for instance by adding extracellular matrix to the culture system. Limitations of the model include the difficulty of studying molecular mechanisms of action, and the natural variation in follicular distribution between patients and tissue pieces that cannot be determined prior to culture. In addition, models based on primary human tissue cannot be developed into test guidelines. The strength of the model lies within its relevance to humans, the possibility to discover biomarkers of exposure and effect, and the lack of animal derived components (3R).
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